Andrea Baragetti Redefines the Dialogue Between Heart and Kidney at EAS Milan
Andrea Baragetti, Associate Professor of Pharmacology at University of Milan, posted on LinkedIn:
”On the frontline of cardiovascular innovation
In Milan, at the European Atherosclerosis Society Advanced Course on Non-Classical Risk Factors, I had the privilege to stand among brilliant scientists and clinicians united by a single mission – to challenge what’s known and redefine the limits of cardiovascular and metabolic medicine.
Gratitude to the organizers and the European Atherosclerosis Society (EAS) for the opportunity to contribute with a talk on upfront therapeutic perspectives on cardio-renal syndrome – a field where the heart and kidney engage in a silent but relentless dialogue, and where every new insight can shift the balance between failure and recovery.
Science is a weapon, innovation is a creed.”
Keep up with Hemostasis Today.
-
Dec 19, 2025, 13:30PPTA Europe’s Holiday Message: Wishing Health, Rest, and Renewal for 2026
-
Dec 19, 2025, 13:22If You Were Reading a “Bible for Blood Donation Volunteers,” What’s the ONE Thing That Must Be in It?
-
Dec 19, 2025, 12:52Julia Owens: Stroke Remains One of the World’s Leading Causes of Death and Disability
-
Dec 19, 2025, 12:03Pradeep Natarajan: Our New Genetic Study of Aortic Stenosis in ~3M
-
Dec 19, 2025, 11:47ESO Blog: Anna Gardin on Stroke Risk in the Era of Climate Extremes
-
Dec 19, 2025, 10:51Sarah Elkourashy Presents Insights on Caplacizumab for TTP at ASH25
-
Dec 19, 2025, 10:08Camilla Lombardi Shares an EHC Nutrition Guide for People with Bleeding Disorders
-
Dec 19, 2025, 09:56Danny Hsu Shares The ”I-WISh” Study by Nichola Cooper on ITP
-
Dec 19, 2025, 09:39Paul Bolaji: A Landmark Achievement -The Historic 1st Nigerian Stroke Leaders’ Summit 2025